These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
827 related articles for article (PubMed ID: 32685003)
1. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling. Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
3. ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway. Wu M; Zhou Y; Fei C; Chen T; Yin X; Zhang L; Ren Z Int J Oncol; 2020 Sep; 57(3):845-857. PubMed ID: 32705157 [TBL] [Abstract][Full Text] [Related]
4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
5. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
6. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development. Zhang N; Chen X Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159 [TBL] [Abstract][Full Text] [Related]
7. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392 [TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Li Y; Liu G; Li X; Dong H; Xiao W; Lu S Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383 [TBL] [Abstract][Full Text] [Related]
10. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma. Zhou Q; Zhang W; Wang Z; Liu S BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B. Xu J; Lu Y; Liu Q; Xia A; Zhao J; Xu X; Sun Q; Qi F; Sun B Cancer Lett; 2020 Mar; 473():1-12. PubMed ID: 31875526 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker. Zhao X; Liu Y; Yu S Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004 [TBL] [Abstract][Full Text] [Related]
15. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice. Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747 [TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA ST8SIA6‑AS1 promotes the migration and invasion of hypoxia‑treated hepatocellular carcinoma cells through the miR‑338/MEPCE axis. Zhang B; Liu Z; Liu J; Cao K; Shan W; Wen Q; Wang R Oncol Rep; 2021 Jan; 45(1):73-82. PubMed ID: 33416148 [TBL] [Abstract][Full Text] [Related]
17. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis. Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma. Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]